Aarkstore.com announce The Latest report -Acacia Pharma Ltd. – Product Pipeline Review – 2012

Document Sample
Aarkstore.com announce The Latest report -Acacia Pharma Ltd. – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Acacia Pharma Ltd. – Product Pipeline Review – 2012


http://www.aarkstore.com/reports/Acacia-Pharma-Ltd-Product-Pipeline-
Review-2012-217855.html




Summary

Global Market Direct’s pharmaceuticals report, “Acacia Pharma Ltd. - Product
Pipeline Review - 2012” provides data on the Acacia Pharma Ltd.’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Acacia Pharma Ltd.’s corporate website, SEC filings, investor
presentations and featured press releases, both from Acacia Pharma Ltd. and
industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Acacia Pharma Ltd. - Brief Acacia Pharma Ltd. overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Acacia Pharma Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 4
List of Figures 4
Acacia Pharma Ltd. Snapshot 5
Acacia Pharma Ltd. Overview 5
Key Information 5
Key Facts 5
Acacia Pharma Ltd. – Research and Development Overview 6
Key Therapeutic Areas 6
Acacia Pharma Ltd. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Acacia Pharma Ltd. – Pipeline Products Glance 10
Acacia Pharma Ltd. Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Acacia Pharma Ltd. – Drug Profiles 11
APD209 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
APD403 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
APD421 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
APD515 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Acacia Pharma Ltd. – Pipeline Analysis 15
Acacia Pharma Ltd. – Pipeline Products by Therapeutic Class 15



List of Figures

List of Tables are also include.
For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review&PubId=&pagenum=1



Acacia Pharma Ltd. – Product Pipeline Review – 2012

Acceleron Pharma, Inc. – Product Pipeline Review – 2012

Access Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Achaogen Inc. – Product Pipeline Review – 2012

Acorda Therapeutics, Inc. – Product Pipeline Review – 2012

Glycotope GmbH – Product Pipeline Review – 2012

Aquinox Pharmaceuticals Inc. – Product Pipeline Review – 2012

Avaxia Biologics, Inc. – Product Pipeline Review – 2012

Bharat Biotech International Limited – Product Pipeline Review – 2012

Bio3 Research S.r.l – Product Pipeline Review – 2012

Cardax Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Cellceutix Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Curacyte AG – Product Pipeline Review – 2012

Fresenius Biotech GmbH – Product Pipeline Review – 2012
Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on
sample@aarkstore.com




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:5
posted:7/20/2012
language:English
pages:4
Description: This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Acacia Pharma Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Acacia Pharma Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team